Home › Funds › New Vernon Capital Holdings II LLC › CPRX

New Vernon Capital Holdings II LLC position in CPRX

CATALYST PHARMACEUTICALS INC

New Vernon Capital Holdings II LLC reported holding 13,521 shares of CPRX (CATALYST PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$425K, representing 0.23% of its reported portfolio and ranking #25 among its reported holdings. New Vernon Capital Holdings II LLC has disclosed CPRX holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)13.52K sh
Reported value held$424.96K
Portfolio Weight0.23%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How New Vernon Capital Holdings II LLC's CPRX position evolved

New Vernon Capital Holdings II LLC first disclosed a stake in CPRX in Q1 2024 at 7,864 shares (US$125K). The position peaked in Q1 2025 at 327,860 shares, worth US$13.5M. Across 9 filings, New Vernon Capital Holdings II LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 13,521 shares valued at US$425K. Notable position changes include a 5531% increase in Q1 2025, a 96% trim in Q2 2025.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 7.86K $125.35K New
Q2 2024 7.86K $121.81K Hold
Q4 2024 5.82K $121.50K New
Q1 2025 327.86K $13.52M Add
Q2 2025 13.52K $293.38K Reduce
Q3 2025 13.52K $266.34K Hold
Q4 2025 13.52K $315.56K Hold
Q1 2026 13.52K $334.75K Hold
Q2 2026 13.52K $424.96K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CPRX and 13F data

CPRX (CATALYST PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 43 other funds we track also report a position in CPRX — the largest reported positions include GLAZER CAPITAL, LLC (US$113.2M), HBK INVESTMENTS L P (US$88.6M), NEXPOINT ASSET MANAGEMENT, L.P. (US$50.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CPRX

All CPRX fund holders →

FAQ

How long has New Vernon Capital Holdings II LLC held CPRX?

New Vernon Capital Holdings II LLC has disclosed CPRX holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

What is New Vernon Capital Holdings II LLC's current position in CPRX?

As of Q2 2026, New Vernon Capital Holdings II LLC holds 13.52K shares of CPRX (CATALYST PHARMACEUTICALS INC), valued at $424.96K, representing 0.23% of its reported portfolio and ranking #25.

Has New Vernon Capital Holdings II LLC been buying or selling CPRX?

In the latest 13F filing (Q2 2026), New Vernon Capital Holdings II LLC held unchanged its position in CPRX. The position peaked in Q1 2025 at 327.86K shares.

Which other funds hold CPRX?

Other major institutional holders of CPRX include GLAZER CAPITAL, LLC, HBK INVESTMENTS L P, NEXPOINT ASSET MANAGEMENT, L.P., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.